Abbott Medical Devices
681
39
80
458
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
14.0%
95 terminated/withdrawn out of 681 trials
82.8%
-3.7% vs industry average
9%
64 trials in Phase 3/4
61%
281 of 458 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (681)
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Role: lead
Portico and Navitor India Clinical Trial
Role: lead
Abbott Structural Heart Device Registry
Role: lead
Valved Graft PMCF Study
Role: lead
Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation
Role: lead
SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacement Therapy
Role: lead
iCorMicA - Stratified Medicine in Angina
Role: collaborator
TECTONIC CAD IVL IDE Study
Role: lead
Grid eXplore Mapping Study
Role: lead
Early System Experience With the Abbott Balloon-expandable TAVI System: First-In-Human Study
Role: lead
Cephea Early Feasibility Study
Role: lead
BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF
Role: lead
Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of Intracoronary Imaging Versus Contemporary Practice
Role: collaborator
LEAP 2 Chronic EFS
Role: lead
Esprit BTK Post-Approval Study
Role: lead
Study of the Natural History of FFR Guided Percutaneous Coronary Intervention
Role: collaborator
ViewFlex X ICE First-in-Human Study
Role: lead
ASCEND CSP IDE Study
Role: lead
A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
Role: collaborator
Trevisio Post-Approval Study
Role: lead